US EditionUHCW to lead trial of new device to address miscarriage symptoms
Summary by Open Access Government
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
UHCW to lead trial of new device to address miscarriage symptoms
University Hospitals Coventry and Warwickshire (UHCW) NHS Trust is to lead a clinical trial of a novel device aimed at addressing miscarriage symptoms Threatened miscarriage, an unofficial term used by health professionals, is when an expectant mother experiences miscarriage symptoms such as bleeding or pain in the first trimester. Currently, progesterone is given to women experiencing threatened miscarriage. Experts from UHCW NHS Trust are le…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
